Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease

(2015) Douglas Walker et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation

(2015) Eun Ji Lee et al.   FASEB JOURNAL

Receptor for Advanced Glycation End-Product Antagonist Reduces Blood-Brain Barrier Damage After Intracerebral Hemorrhage

(2015) F. Yang et al.   STROKE

Soluble RAGEs — Prospects for treating & tracking metabolic and inflammatory disease

(2015) Ann Marie Schmidt   VASCULAR PHARMACOLOGY

Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis

(2015) Judyta K. Juranek et al.   Frontiers in Cellular Neuroscience

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

(2014) Aaron H Burstein et al.   BMC Neurology

Blocking the Receptor for Advanced Glycation End Product Activation Attenuates Autoimmune Myocarditis

(2014) Woo-In Yang et al.   CIRCULATION JOURNAL

Decreased Level of sRAGE in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset

(2014) Anton Glasnovic et al.   NEUROIMMUNOMODULATION

Clinical trial of an inhibitor of RAGE-A  interactions in Alzheimer disease

(2014) D. Galasko et al.   NEUROLOGY

Assessing Functional Performance in the Mdx Mouse Model

(2014) Annemieke Aartsma-Rus et al.   Jove-Journal of Visualized Experiments

Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE

(2013) Judyta K. Juranek et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons

(2013) Janin Lautenschläger et al.   EXPERIMENTAL NEUROLOGY

Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond

(2013) Gurdip Daffu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Enhancing Mitochondrial Calcium Buffering Capacity Reduces Aggregation of Misfolded SOD1 and Motor Neuron Cell Death without Extending Survival in Mouse Models of Inherited Amyotrophic Lateral Sclerosis

(2013) P. A. Parone et al.   JOURNAL OF NEUROSCIENCE

Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice

(2013) Jia Li et al.   PLoS One

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

(2012) Kinnari Sathe et al.   BRAIN

RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice

(2012) J. K. Juranek et al.   DIABETES

A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease

(2012) Rashid Deane et al.   JOURNAL OF CLINICAL INVESTIGATION

Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer’s disease

(2012) Furu Liang et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

(2012) Peter Teismann et al.   NEUROBIOLOGY OF AGING

S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release

(2011) Roberta Bianchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

(2011) Peter M. Andersen et al.   Nature Reviews Neurology

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

(2011) Laura Ferraiuolo et al.   Nature Reviews Neurology

The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration

(2011) S.M. Hearst et al.   NEUROSCIENCE

Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule

(2011) Ana C Calvo et al.   Orphanet Journal of Rare Diseases

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

(2010) S. D. Sussmuth et al.   NEUROLOGY

Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100β expression

(2010) K. Shobha et al.   NEUROSCIENCE LETTERS

A practical guide to understanding Kaplan-Meier curves

(2010) Jason T. Rich et al.   OTOLARYNGOLOGY-HEAD AND NECK SURGERY

RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways

(2010) Linshan Shang et al.   PLoS One

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

(2009) Francesca Santilli et al.   CURRENT MEDICINAL CHEMISTRY

Soluble forms of RAGE in internal medicine

(2009) Natale Vazzana et al.   Internal and Emergency Medicine

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

(2008) J. Iłżecka   ACTA NEUROLOGICA SCANDINAVICA

Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity

(2008) Z Sternberg et al.   Multiple Sclerosis Journal